Randomized Controlled Trials
Research gap analysis derived from 2 medicine papers in our local library.
The gap
Larger, well-designed randomized controlled trials are needed to validate clinical efficacy and establish evidence-based practices for treatments ranging from Sophora flavescens film in postpartum care to efgartigimod in Guillain-Barré syndrome.
Consensus across the literature
The papers collectively leave open the need for rigorous RCTs to confirm findings across various medical interventions.
Research trend
Emerging — attention growing, methods still coalescing.
Supporting evidence — 2 representative gaps
- Effectiveness, safety, and pharmacoeconomic profile of Sophora flavescens film in the treatment of postpartum vaginal dysbiosis: a non-randomized controlled trial (2026) · doi
Large-scale, multicenter, randomized controlled trials are warranted to confirm these findings and to establish definitive evidence for the clinical and economic value of Sophora flavescens film in postpartum care.
Keywords: large scale multicenter randomized controlled trials warranted confirm establish definitive evidence clinical economic value sophora - Correction: Exercise training affects hemodynamics and exercise capacity in cases of heart failure with preserved ejection fraction: a non-randomized controlled trial in individuals aged 65–80 years (2026) · doi
Multi-center randomized controlled trials with larger sample sizes are needed to validate the findings and establish clinical generalizability
Keywords: multi center randomized controlled trials larger sample sizes needed validate establish clinical generalizability
Working on this gap? Publish with us.
Science AI Journal reviews manuscripts in under 15 minutes with 8 specialised AI reviewers calibrated on 23,000+ real peer reviews. Open access, CC BY 4.0.
Related gaps in medicine
- Diagnostic and Prognostic MarkersFurther validation is needed to establish standardized criteria for MRI and sonoelastography in differentiating phyllodes tumors from fibroa…
- Research Method ValidationFurther validation of AI systems and biomarkers is needed across diverse clinical settings and patient populations to ensure safe and effect…
- Validation Across ConditionsFurther studies are needed to confirm the reproducibility and effectiveness of proposed methods under different conditions, including full-s…
- Generalizability of FindingsMost studies lack external validation in diverse populations or settings, questioning the generalizability of their findings.